ES2124348T3 - Solucion de dialisis para hemodialisis extracorporea. - Google Patents
Solucion de dialisis para hemodialisis extracorporea.Info
- Publication number
- ES2124348T3 ES2124348T3 ES94113993T ES94113993T ES2124348T3 ES 2124348 T3 ES2124348 T3 ES 2124348T3 ES 94113993 T ES94113993 T ES 94113993T ES 94113993 T ES94113993 T ES 94113993T ES 2124348 T3 ES2124348 T3 ES 2124348T3
- Authority
- ES
- Spain
- Prior art keywords
- dialysis solution
- renal
- composition
- hemodialysis
- nephrosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000385 dialysis solution Substances 0.000 title abstract 3
- 238000001631 haemodialysis Methods 0.000 title abstract 3
- 230000000322 hemodialysis Effects 0.000 title abstract 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 abstract 2
- 206010029164 Nephrotic syndrome Diseases 0.000 abstract 2
- 208000017169 kidney disease Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000009928 nephrosis Diseases 0.000 abstract 2
- 231100001027 nephrosis Toxicity 0.000 abstract 2
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 abstract 2
- 208000009304 Acute Kidney Injury Diseases 0.000 abstract 1
- 208000037157 Azotemia Diseases 0.000 abstract 1
- 206010064553 Dialysis amyloidosis Diseases 0.000 abstract 1
- 206010018364 Glomerulonephritis Diseases 0.000 abstract 1
- 208000033626 Renal failure acute Diseases 0.000 abstract 1
- 206010062237 Renal impairment Diseases 0.000 abstract 1
- 201000011040 acute kidney failure Diseases 0.000 abstract 1
- 208000012998 acute renal failure Diseases 0.000 abstract 1
- 229940009456 adriamycin Drugs 0.000 abstract 1
- 239000003905 agrochemical Substances 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
- 229960004316 cisplatin Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 201000008383 nephritis Diseases 0.000 abstract 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 1
- -1 phosphoric acid diester Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 229950010131 puromycin Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 208000009852 uremia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE PRESENTA UNA COMPOSICION FARMACEUTICA PARA DESORDENES RENALES Y UNA SOLUCION DIALITICA PARA HEMODIALISIS EXTRACORPORAL QUE COMPRENDE UN DIESTER DE ACIDO FOSFORICO CON LA FORMULA INDICADA (DONDE R1 Y R2 SON IGUALES O DISTINTOS Y CADA UNO REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METILO) O SU SAL FARMACEUTICAMENTE ACEPTABLE. YA QUE LA COMPOSICION DE ESTA INVENCION INHIBE LA FORMACION DE RADICALES LIBRES EN EL CUERPO, PUEDE RESULTAR VENTAJOSO USARLA EN LA PROFILAXIS Y EL TRATAMIENTO DE DESORDENES RENALES COMO GLOMERULONEFRITIS, FALLO RENAL AGUDO, UREMIA, NEFROSIS POR ADRIAMICINA, NEFROSIS POR PUROMICINA, DESORDENES RENALES INDUCIDOS POR CISPLATINA Y GENTAMICINA, DETERIORO RENAL DEBIDO A AGENTES QUIMICOS AGRICOLAS Y NEFRITIS COMPLEJA INMUNE. ADEMAS, LA COMPOSICION TAMBIEN ES UTIL COMO SOLUCION DIALITICA EN HEMODIALISIS EXTRACORPORAL CON EFECTO PROFILACTICO/TERAPEUTICO EN LA AMILOIDOSIS DIALITICA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22538993 | 1993-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2124348T3 true ES2124348T3 (es) | 1999-02-01 |
Family
ID=16828600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94113993T Expired - Lifetime ES2124348T3 (es) | 1993-09-10 | 1994-09-07 | Solucion de dialisis para hemodialisis extracorporea. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5474992A (es) |
| EP (1) | EP0643969B1 (es) |
| KR (1) | KR950007845A (es) |
| AT (1) | ATE173928T1 (es) |
| CA (1) | CA2129509A1 (es) |
| DE (1) | DE69414947T2 (es) |
| ES (1) | ES2124348T3 (es) |
| TW (1) | TW298566B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2244535A1 (en) * | 1995-05-15 | 2000-01-30 | Avon Products, Inc. | Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions |
| US6162450A (en) * | 1995-05-15 | 2000-12-19 | Avon Products, Inc. | Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same |
| US6436969B1 (en) * | 1995-09-12 | 2002-08-20 | Kansas University Medical Center Research Institute Inc. | Dialysis solutions and methods |
| JPH09194375A (ja) * | 1996-01-17 | 1997-07-29 | Senju Pharmaceut Co Ltd | 免疫抑制作用増強剤 |
| US6610206B1 (en) | 1998-10-20 | 2003-08-26 | Advanced Renal Technologies | Buffered compositions for dialysis |
| US7670491B2 (en) * | 1998-10-20 | 2010-03-02 | Advanced Renal Technologies | Buffered compositions for dialysis |
| AU3512400A (en) | 1999-03-05 | 2000-09-21 | Kansas University Medical Center | Novel post-amadori inhibitors of advanced glycation reactions |
| ES2322689T3 (es) * | 1999-09-22 | 2009-06-25 | Advanced Renal Technologies | Uso de un dializado con elevado contenido de citrato. |
| AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| BR0211673A (pt) | 2001-07-27 | 2004-07-13 | Vital Health Sciences Pty Ltd | Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| SE0400523D0 (sv) | 2004-03-01 | 2004-03-01 | Gambro Lundia Ab | A medical solution, a method for producing said medical solution and use thereof |
| JP4847437B2 (ja) | 2004-03-03 | 2011-12-28 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | アルカロイド製剤 |
| KR101037152B1 (ko) * | 2004-04-23 | 2011-05-26 | 엘지전자 주식회사 | 세탁기의 제어 방법 |
| SE0402507D0 (sv) | 2004-10-14 | 2004-10-14 | Gambro Lundia Ab | Medicinsk lösning, förfarande för framställning och användning därav |
| JP2008531603A (ja) * | 2005-03-03 | 2008-08-14 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 脂質低下特性を有する化合物 |
| US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| EP2531047B1 (en) | 2010-02-05 | 2024-11-13 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| MX383940B (es) | 2015-12-09 | 2025-03-14 | Phosphagenics Ltd | Formulación farmacéutica que contiene tocol fosfato. |
| IL267006B2 (en) | 2016-12-21 | 2024-11-01 | Phosphagenics Ltd | Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH25859A (en) * | 1988-01-11 | 1991-12-02 | Takeda Chemical Industries Ltd | Composition for treatment of ischemic disorder |
| CA2026316A1 (en) * | 1989-02-02 | 1990-08-03 | Takashi Awata | Intraocular irrigating solution |
| JP2854631B2 (ja) * | 1989-11-21 | 1999-02-03 | 千寿製薬株式会社 | 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤 |
| DE69125011T2 (de) * | 1991-12-04 | 1997-09-25 | Bertin & Cie | Verfahren und Vorrichtung zur optischen Ferndetektion eines sich in einem beobachteten Raumgebiet befindenden Gases |
-
1994
- 1994-08-04 CA CA002129509A patent/CA2129509A1/en not_active Abandoned
- 1994-08-06 TW TW083107224A patent/TW298566B/zh active
- 1994-08-31 US US08/302,192 patent/US5474992A/en not_active Expired - Fee Related
- 1994-09-07 ES ES94113993T patent/ES2124348T3/es not_active Expired - Lifetime
- 1994-09-07 AT AT94113993T patent/ATE173928T1/de not_active IP Right Cessation
- 1994-09-07 DE DE69414947T patent/DE69414947T2/de not_active Expired - Fee Related
- 1994-09-07 EP EP94113993A patent/EP0643969B1/en not_active Expired - Lifetime
- 1994-09-09 KR KR1019940022796A patent/KR950007845A/ko not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0643969A3 (en) | 1996-03-13 |
| TW298566B (es) | 1997-02-21 |
| DE69414947T2 (de) | 1999-07-08 |
| EP0643969A2 (en) | 1995-03-22 |
| EP0643969B1 (en) | 1998-12-02 |
| DE69414947D1 (de) | 1999-01-14 |
| US5474992A (en) | 1995-12-12 |
| ATE173928T1 (de) | 1998-12-15 |
| KR950007845A (ko) | 1995-04-15 |
| CA2129509A1 (en) | 1995-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2124348T3 (es) | Solucion de dialisis para hemodialisis extracorporea. | |
| Leypoldt | Solute fluxes in different treatment modalities | |
| TNSN01035A1 (fr) | Derives d'ethers de pyrazole nouveaux, et compositions pharmaceutiques les contenant. | |
| SI9111227B (sl) | Farmacevtski preprat z aktivno materijo Flupirtin za zdravljenje bolezni, ki se nanašajo na napetost mišic | |
| EP0276376A3 (en) | A system for the preparation of a fluid intended for a medical treatment | |
| YU11601A (sh) | Derivati fenil jantina | |
| ATE311226T1 (de) | Die glycin-betain für seine antithrombotische verwendung | |
| DK0658110T3 (da) | Anvendelse af norastemizol til behandling af allergisk rhinitis | |
| WO2005044189A2 (en) | Dialysates and methods and systems related thereto | |
| EA200702237A1 (ru) | Композиция и способ для лечения амилоидоза | |
| DE69521388D1 (de) | Verwendung von Glycosaminoglycanen zur Herstellung eines Arzneimittels zur Behandlung des chronischen Nierenversagens | |
| IT9040161A1 (it) | Impianto ad alto rendimento per la attuazione di emodialisi, emofiltrazione plasmaferesi, emodiafiltrazione | |
| DK1289535T3 (da) | Apoptotiske enheder til anvendelse ved behandling af neurodegenerative og andre neurologiske sygdomme | |
| SE8500996D0 (sv) | Method of treatment | |
| DE60108130D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
| FR479154A (fr) | Perfectionnements à la purification, à la clarification et à la stérilisation de l'eau | |
| Matas et al. | Acute renal failure following blunt civilian trauma | |
| WINDER et al. | Edathamil in the treatment of scleroderma and calcinosis cutis | |
| ES2984566T3 (es) | Concentrado de diálisis | |
| AR043003A1 (es) | Compuestos (benzoimidazol-2-il) fenilaminas n-sustituidas, procedimiento para su preparacion, su uso como farmacos o como ayuda en diagnostico, y los medicamentos que las contienen | |
| Oakley et al. | The use of dialysis bath fluid as a vehicle for a drug with a narrow therapeutic index—lithium chloride | |
| DK1143976T3 (da) | Beta-D-2', 3'-didehydro-2', 3'-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner | |
| Baloch et al. | Nephritis and charcot-marie-tooth disease: an unusual association | |
| DE60235965D1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz | |
| Rajhans et al. | Design of wearable dialysis unit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 643969 Country of ref document: ES |